BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AGAH - ECPv5.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AGAH
X-ORIGINAL-URL:https://dev.agah.eu
X-WR-CALDESC:Events for AGAH
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180404
DTEND;VALUE=DATE:20180406
DTSTAMP:20260929T022300
CREATED:20190510T105812Z
LAST-MODIFIED:20190617T063221Z
UID:3094-1522800000-1522972799@dev.agah.eu
SUMMARY:17th Club Phase 1 Annual Meeting
DESCRIPTION:  \nThe Club Phase 1 is pleased to announce you our annual meeting. This meeting is scheduled on April 5th at the “Maison de la Chimie” in Paris with a PBPK symposium on April 4th. You will find in attached file the complete agenda and the registration form. \n\n\n\n	Downloads \nFinal_Programme_17th_ClubPhaseI_Annual_Meeting_05April2018_v11Mar2018 \nFinal_Programme_Symposium_PBPK_04Apr2018_V11Mar2018 \nRegistration_form_04_05April2018_v26Feb2018 \n\n\n\n\n	Final Programme \n\n08.30-09.00\nWelcome coffee/tea\nMorning Sessions \n\n09.00-09.10\nWelcome from the Club Phase 1 President \n\n09.10-09.50\nFrom biomarkers for patient selection to companion\ndiagnostic in drug development\nGérard Sanderink\, Sanofi\, France \n\n09.50-10.30\nAdvances in ECG safety: Phase 1 studies supporting TQT\nwaivers\nPierre Maison-Blanche\, Bichat University Hospital\, APHP\,\nFrance \n\n10.30-11.00\nBreak \n\n11.00-11.40\nMetabolite profiling in early clinical drug development:\nCurrent status and future prospects\nMike Ufer\, Idorsia Pharmaceuticals Ltd\, Switzerland \n\n11.40-12.30\nPIPs’ experience after 10 years: Inclusion of the paediatric\ndevelopment early is necessary when requested by regulation\nSylvie Benchetrit\, French referent to the EMA PDCO\, France \n\n12.30-14.00\nLunch \nAfternoon Sessions \n\n14.00-14.30\nActivity-based protein profiling reveals off-target proteins of\nthe FAAH inhibitor BIA 10-2474\nPr. Mario Van Der Stelt\, Leiden University\, The Netherlands \n\n14.30-15.00\nIn silico tools for early phase side effect profiling and off\ntarget prediction of potential drug candidates\nPr. Thierry Langer\, Prestwick Chemical referent\, Vienna\nUniversity\, Austria \n\n15.00-15.20\nPanel discussion with Pr. Van Der Stelt\, Pr. Thierry Langer and\nthe audience \n\n15.20-15.50\nBreak \n\n15.50-16.30\nCAR T-cell: Engineering immune cells to treat cancer\nRoman Galetto\, Cellectis SA\, France \n\n16.30-17.10\nCentral Nervous System biomarkers with a special focus on\nelectrophysiology\nAlain Patat\, Biotrial\, France \n\n17.10-17.30\nConclusions and presentation of the next events of the Club\nPhase 1 \n\n\n\n\n	Date \n05 April 2018\n\n\n\n\n	REGISTRATION \nRequired before 30 March 2018\nCost (without accommodation)\nClub Phase I – 17th annual meeting\nonly (05 April 2018)\nMember (2018): 200 €\nNon-Member: 300 €\nClub Phase I – 17th annual meeting +\nPBPK symposium (04 and 05 April\n2018)\nMember (2018): 300 €\nNon-Member: 400 € \n\n\n\n\n	Location  \nMaison de la Chimie\n28\, rue Saint Dominique\n75007 PARIS\nFrance\nPhone: (+33)1 40 62 27 00 \n\n\n\n\n	Access  \nRER: Line C\, Invalides Station\nSubway: Lines 8\, 12 and 13\, Assemblée\nNationale\, Solférino or Invalides Stations\nBus: Lines 63\, 69\, 83\, 93 and 94 RER: Line C\, Invalides Station \n\n\n\n\n	Closest hotels \nSaint-Dominique Hotel\n62\, rue Saint-Dominique \nBest Western Tour Eiffel Invalides\n35\, boulevard de la Tour-Maubourg \nHôtel de Varenne\n44\, rue de Bourgogne \nBooking directly with the Hotel. \n\n\n\n\n	Contact \nleclubphase1@gmail.com \nRegistration form online on\nwww.clubphase1.fr
URL:https://dev.agah.eu/event/17th-club-phase-1-annual-meeting-2/
LOCATION:Club Phase 1 Workshop\, Paris\, Frankreich
CATEGORIES:Training
END:VEVENT
END:VCALENDAR